Innovation Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Innovation Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2023.
  • Innovation Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 10, 2023 was 514M shares, a 5.28% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 514M +25.8M +5.28% Sep 10, 2023 10-K 2023-09-28
Q1 2023 488M +31.7M +6.95% Feb 15, 2023 10-Q 2023-02-15
Q3 2022 488M +51.1M +11.7% Sep 22, 2022 10-K 2022-09-28
Q1 2022 457M +38.4M +9.19% May 11, 2022 10-Q 2022-05-13
Q4 2021 457M +38.5M +9.21% Feb 9, 2022 10-Q 2022-02-14
Q3 2021 437M +93.5M +27.2% Sep 22, 2021 10-K 2021-09-27
Q1 2021 418M +125M +42.8% May 10, 2021 10-Q 2021-05-13
Q4 2020 418M +188M +81.8% Feb 10, 2021 10-Q 2021-02-22
Q3 2020 344M +132M +62.4% Sep 10, 2020 10-K 2020-09-14
Q1 2020 293M May 11, 2020 10-Q 2020-05-14
Q4 2019 230M +50.4M +28.1% Feb 8, 2020 10-Q 2020-02-13
Q3 2019 212M +47.9M +29.3% Sep 23, 2019 10-K 2019-09-30
Q4 2018 180M +33.9M +23.3% Feb 5, 2019 10-Q 2019-02-08
Q3 2018 164M +25.8M +18.7% Nov 2, 2018 10-Q 2018-11-08
Q1 2018 155M +23.7M +18% May 6, 2018 10-Q 2018-05-10
Q4 2017 146M +19.3M +15.3% Jan 31, 2018 10-Q 2018-02-07
Q3 2017 138M +13.3M +10.6% Sep 1, 2017 10-K 2017-09-11
Q1 2017 131M +8.84M +7.21% May 1, 2017 10-Q 2017-05-09
Q4 2016 126M +6.48M +5.4% Jan 27, 2017 10-Q 2017-02-09
Q3 2016 125M +6.11M +5.16% Aug 31, 2016 10-K 2016-09-13
Q1 2016 123M +4.82M +4.1% May 5, 2016 10-Q 2016-05-09
Q4 2015 120M +3.29M +2.82% Feb 3, 2016 10-Q 2016-02-08
Q3 2015 119M +6.81M +6.1% Oct 31, 2015 10-Q 2015-11-09
Q1 2015 118M +9.69M +8.97% May 1, 2015 10-Q 2015-05-11
Q4 2014 117M +10.8M +10.2% Feb 5, 2015 10-Q 2015-02-09
Q3 2014 112M Sep 5, 2014 10-K 2014-09-15
Q1 2014 108M +10.7M +11% May 7, 2014 10-Q/A 2014-05-16
Q4 2013 106M +10.3M +10.7% Jan 20, 2014 10-Q 2014-02-10
Q1 2013 97.4M +5.89M +6.44% May 8, 2013 10-Q 2013-05-20
Q4 2012 95.6M +270K +0.28% Feb 11, 2013 10-Q 2013-02-13
Q3 2012 93.2M +646K +0.7% Oct 31, 2012 10-Q 2012-11-19
Q1 2012 91.5M May 10, 2012 10-Q 2012-05-18
Q4 2011 95.4M Feb 10, 2012 10-Q 2012-02-14
Q3 2011 92.5M Oct 31, 2011 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.